Public Affairs

  1. An Agenda for the 2012 Conventions

    While political conventions are “networking on steroids,” they also provide serious business opportunities. The public affairs specialists at VOX Global, a Fleishman-Hillard company, share a strategy for engagement at the 2012 conventions.

    Posted on January 31st, 2012 | More · · · ·

  2. Inside the World of the WEF

    The World Economic Forum might be “a dream” for communications and public affairs professionals, but how can it improve? In a PRWeek column, Jack Modzelewski, Fleishman-Hillard president of the Americas, looks at this year’s “biggest thematic set change.”

    Read: Positive Movements Start in Davos

    Posted on January 30th, 2012 | More · ·

  3. The E-Doctor Will See You Now

    Will the cloud help when you’re under the weather? Pharma specialist Mark Senak looks at how technology has changed the patient experience, suggesting physicians might not realize “the change it demands.”

    Posted on January 26th, 2012 | More · · · ·

  4. Survey Says: Government Needs Social Media

    Our communications specialists in Canada look at some research findings and explain why government 2.0 is “no longer an option.”

    Posted on January 26th, 2012 | More · ·

  5. What Effect Will a Nay Vote Have on UK Politics?

    Will an intraparty disagreement cause headaches for Deputy Prime Minister Nick Clegg? In a PRWeek article, public affairs specialist Nick Williams weighs in on former Liberal Democrat leader Paddy Ashdown’s vote — and why it will be one of many lines “drawn in the sand.”

    Read: Paddy Ashdown’s Defiance Over Benefits Cap Causing Headaches for Nick Clegg

    Posted on January 25th, 2012 | More

  6. Putting Search Results on (Clinical) Trial

    The Internet can be an important medical resource — if the right information is found. Pharma specialist Mark Senak experiments with search results and explains why what “didn’t come up” is worth noting.

    Posted on January 24th, 2012 | More · ·

  7. Will Passion Be Chemicals’ Reaction?

    The chemicals industry appears to have an image problem, and passion might be part of the solution. In a column in Chemistry & Industry, reputation specialist Nick Andrews explains what the automobile industry can teach chemicals about a future “in which others can believe.”

    Read: Communicating With Passion

    Posted on January 13th, 2012 | More ·

  8. New FDA Guidance Provides Answers, Raises Questions

    Pharma specialist Mark Senak reviews new FDA guidance on off-label use, suggesting why it might start “raising more questions than are answered.”

    Posted on January 6th, 2012 | More · ·

  9. The Consequences of the Iowa Caucus

    Following his win in Iowa, is GOP candidate Mitt Romney prepared to “fight a four-front war”? In a Huffington Post column, Robert Hoopes, president of VOX Global, breaks down the road ahead, including the “wrath of the attack dog.”

    Read: Results and Consequences

    Posted on January 4th, 2012 | More ·

  10. New Year Brings New Look for FDA

    Pharma specialist Mark Senak shares some thoughts on the FDA’s new website, from a “few bugs” to its “most compelling feature.”

    Posted on January 3rd, 2012 | More · ·

Subscribe Subscribe to RSS

Learn More: Public Affairs

Opinions

 

Archives